Truist Financial Remains a Buy on Willis Towers Watson (WTW)

Truist Financial analyst Mark Hughes reiterated a Buy on Willis Towers Watson (WTW) with a $400 price target. TipRanks says Hughes is a top analyst. WTW also saw Buy ratings from Mizuho, while Barclays kept a Hold. WTW reported Q2 revenue of $2.47B and net profit of $229M, versus $2.26B and $331M a year earlier.

Original reporting
Published Aug 1, 2026, 12:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 1, 2026, 3:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Truist Financial Remains a Buy on Willis Towers Watson (WTW) — source image
Decision brief

The 30-second read

$WTWBullishLow
01

Why it matters

For traders, the actionable element is the $400 price target reiteration, which may influence short-term sentiment but lacks a new fundamental driver.

02

Market read

This is primarily sell-side rating/target reiteration for WTW, with minor supporting context from cited earnings and insider buying.

03

What to watch

The article cites insider buying and prior earnings comparisons, but does not provide the analyst’s thesis, valuation assumptions, or any fresh company-specific operational update.

Relevance 4/10Novelty 3/10Timing: report released today

Background

The piece is framed as an analyst note: Truist maintained Buy on WTW, with another Buy cited from Mizuho and a Hold from Barclays.

Company-level read

Ticker impact

$WTWBullishMedium confidence
Context

The article says Truist Financial maintained a Buy on Willis Towers Watson and set a $400 price target in a report released today.

Expected impact

Likely limited near-term impact unless the market is already repositioning around analyst target changes.

Evidence & confidence

The only new, company-specific facts are the maintained Buy rating and the stated $400 target; the earnings figures cited are not clearly identified as newly released in this article.

Market effects

Reinforces positive sell-side sentiment toward financial services/insurance brokerage equities, but without new sector data.

No clear regional market linkage beyond US-listed coverage.

No global macro or cross-border transaction details provided.

Counterpoint

A maintained rating and target can lag underlying fundamentals; without new earnings, guidance, or deal news, the market may discount it.

Key entities

  • Willis Towers Watson

    Subject of the article, receiving a maintained Buy rating and $400 price target from Truist.

  • Truist Financial

    Maintained a Buy rating on WTW and set a $400 price target in a report released today.

  • Barclays

    Maintained a Hold rating on WTW in a report issued the same day.

  • Mizuho Securities

    Issued a Buy rating on WTW in a report issued the same day.

Related articles

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Willis Towers Watson (WTW) reported Q2 2026 results on an earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). It outlined Propel, targeting $400 million run-rate savings by 2028 and enterprise margin of about 30%, plus $450 million Q2 buybacks.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Willis Towers Watson (WTW) reported Q2 2026 results on its earnings call. Management cited 5% organic revenue growth, adjusted diluted EPS of $3.35 (+17% YoY), and a 19.5% adjusted operating margin (+100 bps). The company targets $400m run-rate savings by 2028 from a ~$625m AI investment and $360m free cash flow in the first half of 2026.

$WTWMed

Why is Willis Towers Watson stock climbing today?

Willis Towers Watson (WTW) shares rose about 1.5% after Q2 results beat expectations and prompted analyst target increases. According to the company, adjusted EPS was $3.35 vs $3.13 consensus, revenue about $2.47B vs $2.41B, with 5% organic growth. Goldman raised its target to $385 and UBS to $405 (both Buy), while Citigroup downgraded to Neutral with a $345 target.

$WTWMedAI 8/10

WTW (WTW) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Carl A. Hess Chief Financial Officer - Andrew Krasner President of Health, Wealth & Career - Julie Gebauer President of Risk & Broking - Lucy Clarke TAKEAWAYS Organic Revenue Growth -- 5%, reflecting strength in the Risk & Broking segment and steady performance in Health, Wealth & Career.